These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 17884696)
61. Screening for drug discovery: the leading question. Smith A Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563 [No Abstract] [Full Text] [Related]
62. Biodiversity as a source of anticancer drugs. Tan G; Gyllenhaal C; Soejarto DD Curr Drug Targets; 2006 Mar; 7(3):265-77. PubMed ID: 16515527 [TBL] [Abstract][Full Text] [Related]
63. Natural products in drug discovery: present status and perspectives. Molinari G Adv Exp Med Biol; 2009; 655():13-27. PubMed ID: 20047031 [TBL] [Abstract][Full Text] [Related]
64. Advances in drug discovery and biochemical studies. Kita K; Shiomi K; Omura S Trends Parasitol; 2007 May; 23(5):223-9. PubMed ID: 17383234 [TBL] [Abstract][Full Text] [Related]
67. A new approach for anthelmintic discovery for humans. Geary TG; Chibale K; Abegaz B; Andrae-Marobela K; Ubalijoro E Trends Parasitol; 2012 May; 28(5):176-81. PubMed ID: 22424638 [TBL] [Abstract][Full Text] [Related]
68. Leishmaniasis: drug resistance and natural products (review). Polonio T; Efferth T Int J Mol Med; 2008 Sep; 22(3):277-86. PubMed ID: 18698485 [TBL] [Abstract][Full Text] [Related]
69. Natural products as leads to potential drugs: an old process or the new hope for drug discovery? Newman DJ J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402 [No Abstract] [Full Text] [Related]
70. Systematics-guided bioprospecting for bioactive microbial natural products. Liu X; Bolla K; Ashforth EJ; Zhuo Y; Gao H; Huang P; Stanley SA; Hung DT; Zhang L Antonie Van Leeuwenhoek; 2012 Jan; 101(1):55-66. PubMed ID: 22086462 [TBL] [Abstract][Full Text] [Related]
71. Chemical biology--identification of small molecule modulators of cellular activity by natural product inspired synthesis. Hübel K; Lessmann T; Waldmann H Chem Soc Rev; 2008 Jul; 37(7):1361-74. PubMed ID: 18568162 [TBL] [Abstract][Full Text] [Related]
72. Anticancer and chemopreventing natural products: some biochemical and therapeutic aspects. Karikas GA J BUON; 2010; 15(4):627-38. PubMed ID: 21229622 [TBL] [Abstract][Full Text] [Related]
73. Establishment of the platform for reverse chemical genetics targeting novel protein-protein interactions. Koga H Mol Biosyst; 2006 Mar; 2(3-4):159-64. PubMed ID: 16880933 [TBL] [Abstract][Full Text] [Related]
74. Natural products to drugs: natural product-derived compounds in clinical trials. Butler MS Nat Prod Rep; 2008 Jun; 25(3):475-516. PubMed ID: 18497896 [TBL] [Abstract][Full Text] [Related]
75. Natural products as a foundation for drug discovery. Beutler JA Curr Protoc Pharmacol; 2009 Sep; Chapter 9():Unit 9.11. PubMed ID: 22294405 [TBL] [Abstract][Full Text] [Related]
76. Anti-infectives: can cellular screening deliver? Keller TH; Shi PY; Wang QY Curr Opin Chem Biol; 2011 Aug; 15(4):529-33. PubMed ID: 21723774 [TBL] [Abstract][Full Text] [Related]
77. Natural products to drugs: natural product derived compounds in clinical trials. Butler MS Nat Prod Rep; 2005 Apr; 22(2):162-95. PubMed ID: 15806196 [TBL] [Abstract][Full Text] [Related]
78. Automated high-throughput system to fractionate plant natural products for drug discovery. Tu Y; Jeffries C; Ruan H; Nelson C; Smithson D; Shelat AA; Brown KM; Li XC; Hester JP; Smillie T; Khan IA; Walker L; Guy K; Yan B J Nat Prod; 2010 Apr; 73(4):751-4. PubMed ID: 20232897 [TBL] [Abstract][Full Text] [Related]
79. The academic pursuit of screening. Nat Chem Biol; 2007 Aug; 3(8):433. PubMed ID: 17637766 [TBL] [Abstract][Full Text] [Related]
80. Mass spectrometric techniques for label-free high-throughput screening in drug discovery. Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]